Clinical Trial Update: Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing immediate versus deferred injections of poly-L-lactic acid for HIV-associated facial lipoatrophy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hiv-associated Lipodystrophy

Drugs mentioned

• Poly-L-lactic acid (poly-L-lactic acid)

Snippet

Sponsor: Kirby Institute | Conditions: HIV-Associated Lipodystrophy, HIV Infections | Phase 4 | Status: TERMINATED